Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.3200
-0.0123 (-3.70%)
At close: May 19, 2026, 4:00 PM EDT
0.3301
+0.0101 (3.16%)
After-hours: May 19, 2026, 7:38 PM EDT
Jupiter Neurosciences Market Cap
Jupiter Neurosciences has a market cap or net worth of $11.61 million as of May 19, 2026. Its market cap has decreased by -43.62% in one year.
Market Cap
11.61M
Enterprise Value
14.08M
1-Year Change
-43.62%
Ranking
Category
Stock Price
$0.32
Market Cap Chart
Since the IPO on December 3, 2024, Jupiter Neurosciences's market cap has decreased from $132.40M to $11.61M, a decrease of -91.23%. That is a compound annual growth rate of -81.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 11.61M | -66.94% |
| Dec 31, 2025 | 35.11M | -90.09% |
| Dec 31, 2024 | 354.21M | 167.54% |
| Dec 3, 2024 | 132.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 13.35M |
| Vyome Holdings | 13.27M |
| Cyclerion Therapeutics | 13.19M |
| Cellectar Biosciences | 13.10M |
| BioLineRx | 12.52M |
| Phio Pharmaceuticals | 12.43M |
| GT Biopharma | 12.43M |
| Intensity Therapeutics | 12.27M |